Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
ARX vs RYAN vs KNSL vs ACGL vs ERIE
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
Insurance - Property & Casualty
Insurance - Diversified
Insurance - Brokers
ARX vs RYAN vs KNSL vs ACGL vs ERIE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Insurance - Specialty | Insurance - Property & Casualty | Insurance - Diversified | Insurance - Brokers |
| Market Cap | $1.45B | $4.08B | $7.02B | $33.60B | $10.09B |
| Revenue (TTM) | $796M | $3.16B | $1.92B | $19.93B | $4.33B |
| Net Income (TTM) | $-1.43B | $132M | $527M | $4.40B | $571M |
| Gross Margin | 67.1% | 69.4% | 36.9% | 37.2% | 18.1% |
| Operating Margin | -166.0% | 16.6% | 27.2% | 25.0% | 17.0% |
| Forward P/E | 19.8x | 15.3x | 14.7x | 10.1x | 17.3x |
| Total Debt | $121M | $3.53B | $224M | $2.73B | $0.00 |
| Cash & Equiv. | $1.80B | $158M | $163M | $993M | $346M |
ARX vs RYAN vs KNSL vs ACGL vs ERIE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Ryan Specialty Hold… (RYAN) | 100 | 106.8 | +6.8% |
| Kinsale Capital Gro… (KNSL) | 100 | 169.7 | +69.7% |
| Arch Capital Group … (ACGL) | 100 | 241.8 | +141.8% |
| Erie Indemnity Comp… (ERIE) | 100 | 118.2 | +18.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARX vs RYAN vs KNSL vs ACGL vs ERIE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, ARX doesn't own a clear edge in any measured category.
RYAN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.19, current ratio 7.51x
- 21.3% revenue growth vs ARX's -11.6%
KNSL has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 18.0%, EPS growth 21.8%, 3Y rev CAGR 30.7%
- 15.8% 10Y total return vs ACGL's 315.5%
- Combined ratio 0.7 vs ARX's 3.6 (lower = better underwriting)
- 0.2% yield, 10-year raise streak, vs ERIE's 2.2%, (1 stock pays no dividend)
ACGL is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.35 vs ERIE's 1.27
- Lower P/E (10.1x vs 17.3x), PEG 0.35 vs 1.27
- -0.3% vs RYAN's -53.5%
ERIE ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 2 yrs, beta 0.13, yield 2.2%
- Beta 0.13, yield 2.2%, current ratio 1.27x
- Beta 0.13 vs ARX's 0.38
- 17.3% ROA vs ARX's -18.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.3% revenue growth vs ARX's -11.6% | |
| Value | Lower P/E (10.1x vs 17.3x), PEG 0.35 vs 1.27 | |
| Quality / Margins | Combined ratio 0.7 vs ARX's 3.6 (lower = better underwriting) | |
| Stability / Safety | Beta 0.13 vs ARX's 0.38 | |
| Dividends | 0.2% yield, 10-year raise streak, vs ERIE's 2.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | -0.3% vs RYAN's -53.5% | |
| Efficiency (ROA) | 17.3% ROA vs ARX's -18.8% |
ARX vs RYAN vs KNSL vs ACGL vs ERIE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ARX vs RYAN vs KNSL vs ACGL vs ERIE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACGL leads in 3 of 6 categories
RYAN leads 1 • ERIE leads 1 • ARX leads 0 • KNSL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RYAN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACGL is the larger business by revenue, generating $19.9B annually — 25.0x ARX's $796M. KNSL is the more profitable business, keeping 27.5% of every revenue dollar as net income compared to ARX's -179.0%. On growth, RYAN holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $796M | $3.2B | $1.9B | $19.9B | $4.3B |
| EBITDAEarnings before interest/tax | -$1.3B | $743M | $533M | $5.2B | $786M |
| Net IncomeAfter-tax profit | -$1.4B | $132M | $527M | $4.4B | $571M |
| Free Cash FlowCash after capex | $445M | $555M | $1.0B | $6.1B | $537M |
| Gross MarginGross profit ÷ Revenue | +67.1% | +69.4% | +36.9% | +37.2% | +18.1% |
| Operating MarginEBIT ÷ Revenue | -166.0% | +16.6% | +27.2% | +25.0% | +17.0% |
| Net MarginNet income ÷ Revenue | -179.0% | +4.2% | +27.5% | +22.1% | +13.2% |
| FCF MarginFCF ÷ Revenue | +55.9% | +17.6% | +52.9% | +30.7% | +12.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -15.0% | +15.2% | +10.2% | +7.3% | +2.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +2.4% | -100.0% | +39.0% | +7.9% |
Valuation Metrics
ACGL leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.1x trailing earnings, ACGL trades at a 88% valuation discount to RYAN's 67.0x P/E. Adjusting for growth (PEG ratio), ACGL offers better value at 0.28x vs ERIE's 1.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.4B | $4.1B | $7.0B | $33.6B | $10.1B |
| Enterprise ValueMkt cap + debt − cash | -$231M | $7.5B | $7.1B | $35.3B | $9.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.80x | 67.04x | 14.00x | 8.12x | 20.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.82x | 15.32x | 14.66x | 10.10x | 17.26x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.34x | 0.28x | 1.51x |
| EV / EBITDAEnterprise value multiple | — | 8.17x | 11.06x | 6.83x | 12.24x |
| Price / SalesMarket cap ÷ Revenue | 2.80x | 1.34x | 3.75x | 1.69x | 2.48x |
| Price / BookPrice ÷ Book value/share | 3.53x | 7.00x | 3.60x | 1.47x | 5.04x |
| Price / FCFMarket cap ÷ FCF | 3.25x | 7.09x | 7.09x | 5.48x | 17.68x |
Profitability & Efficiency
ERIE leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KNSL delivers a 28.0% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-2 for ARX. ACGL carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to RYAN's 2.82x. On the Piotroski fundamental quality scale (0–9), KNSL scores 7/9 vs ERIE's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.5% | +10.8% | +28.0% | +19.0% | +25.0% |
| ROA (TTM)Return on assets | -18.8% | +1.3% | +9.1% | +5.9% | +17.3% |
| ROICReturn on invested capital | — | +10.8% | +26.6% | +15.4% | +29.5% |
| ROCEReturn on capital employed | -18.4% | +6.4% | +14.2% | +11.6% | +32.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.17x | 2.82x | 0.11x | 0.11x | — |
| Net DebtTotal debt minus cash | -$1.7B | $3.4B | $61M | $1.7B | -$346M |
| Cash & Equiv.Liquid assets | $1.8B | $158M | $163M | $993M | $346M |
| Total DebtShort + long-term debt | $121M | $3.5B | $224M | $2.7B | $0 |
| Interest CoverageEBIT ÷ Interest expense | 0.05x | 2.29x | 47.02x | 34.86x | — |
Total Returns (Dividends Reinvested)
ACGL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACGL five years ago would be worth $25,380 today (with dividends reinvested), compared to $5,091 for ARX. Over the past 12 months, ACGL leads with a -0.3% total return vs RYAN's -53.5%. The 3-year compound annual growth rate (CAGR) favors ACGL at 8.9% vs ARX's -20.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -13.6% | -37.2% | -22.7% | +0.5% | -20.3% |
| 1-Year ReturnPast 12 months | -49.1% | -53.5% | -33.5% | -0.3% | -37.3% |
| 3-Year ReturnCumulative with dividends | -49.1% | -24.6% | -7.4% | +29.1% | +0.8% |
| 5-Year ReturnCumulative with dividends | -49.1% | +19.7% | +98.7% | +153.8% | +21.1% |
| 10-Year ReturnCumulative with dividends | -49.1% | +19.7% | +1576.0% | +315.5% | +170.5% |
| CAGR (3Y)Annualised 3-year return | -20.2% | -9.0% | -2.5% | +8.9% | +0.3% |
Risk & Volatility
ACGL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ACGL is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than ARX's 0.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACGL currently trades 91.2% from its 52-week high vs ARX's 43.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.38x | 0.19x | 0.25x | -0.01x | 0.13x |
| 52-Week HighHighest price in past year | $31.18 | $72.50 | $512.76 | $103.39 | $380.67 |
| 52-Week LowLowest price in past year | $9.18 | $29.28 | $293.78 | $82.45 | $210.06 |
| % of 52W HighCurrent price vs 52-week peak | +43.3% | +43.5% | +59.1% | +91.2% | +57.4% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 39.4 | 27.7 | 43.4 | 37.3 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 2.2M | 261K | 1.9M | 227K |
Analyst Outlook
Evenly matched — KNSL and ERIE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ARX as "Buy", RYAN as "Buy", KNSL as "Hold", ACGL as "Buy". Consensus price targets imply 42.8% upside for KNSL (target: $433) vs 10.3% for ACGL (target: $104). For income investors, ERIE offers the higher dividend yield at 2.21% vs KNSL's 0.22%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | — |
| Price TargetConsensus 12-month target | $16.60 | $41.56 | $433.00 | $104.00 | — |
| # AnalystsCovering analysts | 9 | 19 | 13 | 34 | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.7% | +0.2% | +0.0% | +2.2% |
| Dividend StreakConsecutive years of raises | — | 0 | 10 | 0 | 2 |
| Dividend / ShareAnnual DPS | — | $0.22 | $0.68 | $0.02 | $4.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +12.1% | +0.1% | +1.3% | +5.6% | 0.0% |
ACGL leads in 3 of 6 categories (Valuation Metrics, Total Returns). RYAN leads in 1 (Income & Cash Flow). 1 tied.
ARX vs RYAN vs KNSL vs ACGL vs ERIE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ARX or RYAN or KNSL or ACGL or ERIE a better buy right now?
For growth investors, Ryan Specialty Holdings, Inc.
(RYAN) is the stronger pick with 21. 3% revenue growth year-over-year, versus -11. 6% for Accelerant Holdings (ARX). Arch Capital Group Ltd. (ACGL) offers the better valuation at 8. 1x trailing P/E (10. 1x forward), making it the more compelling value choice. Analysts rate Accelerant Holdings (ARX) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ARX or RYAN or KNSL or ACGL or ERIE?
On trailing P/E, Arch Capital Group Ltd.
(ACGL) is the cheapest at 8. 1x versus Ryan Specialty Holdings, Inc. at 67. 0x. On forward P/E, Arch Capital Group Ltd. is actually cheaper at 10. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Arch Capital Group Ltd. wins at 0. 35x versus Erie Indemnity Company's 1. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ARX or RYAN or KNSL or ACGL or ERIE?
Over the past 5 years, Arch Capital Group Ltd.
(ACGL) delivered a total return of +153. 8%, compared to -49. 1% for Accelerant Holdings (ARX). Over 10 years, the gap is even starker: KNSL returned +1576% versus ARX's -49. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ARX or RYAN or KNSL or ACGL or ERIE?
By beta (market sensitivity over 5 years), Arch Capital Group Ltd.
(ACGL) is the lower-risk stock at -0. 01β versus Accelerant Holdings's 0. 38β — meaning ARX is approximately -3437% more volatile than ACGL relative to the S&P 500. On balance sheet safety, Arch Capital Group Ltd. (ACGL) carries a lower debt/equity ratio of 11% versus 3% for Ryan Specialty Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ARX or RYAN or KNSL or ACGL or ERIE?
By revenue growth (latest reported year), Ryan Specialty Holdings, Inc.
(RYAN) is pulling ahead at 21. 3% versus -11. 6% for Accelerant Holdings (ARX). On earnings-per-share growth, the picture is similar: Kinsale Capital Group, Inc. grew EPS 21. 8% year-over-year, compared to -54. 5% for Accelerant Holdings. Over a 3-year CAGR, ARX leads at 34. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ARX or RYAN or KNSL or ACGL or ERIE?
Kinsale Capital Group, Inc.
(KNSL) is the more profitable company, earning 26. 9% net margin versus -275. 8% for Accelerant Holdings — meaning it keeps 26. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KNSL leads at 33. 8% versus -255. 8% for ARX. At the gross margin level — before operating expenses — RYAN leads at 90. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ARX or RYAN or KNSL or ACGL or ERIE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Arch Capital Group Ltd. (ACGL) is the more undervalued stock at a PEG of 0. 35x versus Erie Indemnity Company's 1. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Arch Capital Group Ltd. (ACGL) trades at 10. 1x forward P/E versus 19. 8x for Accelerant Holdings — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KNSL: 42. 8% to $433. 00.
08Which pays a better dividend — ARX or RYAN or KNSL or ACGL or ERIE?
In this comparison, ERIE (2.
2% yield), RYAN (0. 7% yield), KNSL (0. 2% yield) pay a dividend. ARX, ACGL do not pay a meaningful dividend and should not be held primarily for income.
09Is ARX or RYAN or KNSL or ACGL or ERIE better for a retirement portfolio?
For long-horizon retirement investors, Kinsale Capital Group, Inc.
(KNSL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 25), +1576% 10Y return). Both have compounded well over 10 years (KNSL: +1576%, ARX: -49. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ARX and RYAN and KNSL and ACGL and ERIE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ARX is a small-cap quality compounder stock; RYAN is a small-cap high-growth stock; KNSL is a small-cap high-growth stock; ACGL is a mid-cap deep-value stock; ERIE is a mid-cap quality compounder stock. RYAN, ERIE pay a dividend while ARX, KNSL, ACGL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.